9 METERS BIOPHARMA, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
9 Meters Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q1 2023.
  • 9 Meters Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2023 was $97.7K, a 36.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $97.7K -$56K -36.4% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $112K -$54.3K -32.6% Dec 31, 2022 10-Q 2023-05-15
Q3 2022 $127K -$52.7K -29.4% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $140K -$51.1K -26.7% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $154K -$49.6K -24.4% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $167K -$48.1K -22.4% Dec 31, 2021 10-K 2023-03-28
Q3 2021 $179K -$46.7K -20.7% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $191K +$177K +1202% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $203K +$174K +601% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $215K +$172K +401% Dec 31, 2020 10-K 2022-03-23
Q3 2020 $226K +$170K +301% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $14.7K -$54.6K -78.8% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $29K -$53K -64.7% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $42.8K Dec 31, 2019 10-K 2021-03-22
Q3 2019 $56.3K Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $69.3K Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $82K Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.